Collegium Pharmaceutical, Inc.(COLL)股价在周四盘后大涨7.32%,引发市场广泛关注。这一涨幅的主要原因是公司公布的最新一季度财报业绩超出了分析师预期。
具体来看,Collegium制药公司公布的最新一季度财报显示,公司每股收益为1.75美元,超出分析师共识预期的1.54美元,超出幅度高达13.64%;季度销售额达到18.195亿美元,也高于分析师预期的17.979亿美元,增长幅度为1.2%。
Collegium制药公司本次财报业绩出色,体现了公司的良好财务状况和盈利能力。这一利好消息显然受到资本市场的高度欢迎和认可,从而推动了公司股价在盘后大幅上扬。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.